NABP NAPLEX Exam - Topic 5 Question 97 Discussion

Actual exam question for NABP's NAPLEX exam

Question #: 97
Topic #: 5

[All NAPLEX Questions]

Which of the following antidiabetic medication works by decreasing glucose reabsorption?

AMiglitol

BLinagliptin

CPioglitazone

DExenatide

EEmpagliflozin

Show Suggested Answer

Suggested Answer: C

Omeprazole is CYP2C19 inhibitor which can prolong the elimination of warfarin, particularly R-warfarin. R- warfarin is partially metabolized by CYP2C19. The combined use of omeprazole and warfarin has been associated with reports of increased INR and prothrombin time (PT).

by Shelton at Nov 18, 2024, 03:59 AM

Limited Time Offer

25%

Off

Get Premium NAPLEX Questions as Interactive Web-Based Practice Test or PDF

Contribute your Thoughts:

Submit Cancel

Aileen

3 months ago

Yup, definitely Empagliflozin!

upvoted 0 times

...

Javier

3 months ago

I thought Pioglitazone was the answer, but I guess not.

upvoted 0 times

...

Paola

3 months ago

Wait, isn't that just for glucose excretion?

upvoted 0 times

...

Clarence

4 months ago

Totally agree, it's an SGLT2 inhibitor.

upvoted 0 times

...

Lera

4 months ago

Empagliflozin is the one that decreases glucose reabsorption!

upvoted 0 times

...

Rasheeda

4 months ago

I practiced a similar question where Empagliflozin was mentioned as an SGLT2 inhibitor, which is related to glucose reabsorption.

upvoted 0 times

...

Becky

4 months ago

Linagliptin is a DPP-4 inhibitor, right? I feel like I might be mixing up the mechanisms here.

upvoted 0 times

...

Clay

4 months ago

I remember studying that Miglitol is an alpha-glucosidase inhibitor, so it doesn't fit this question.

upvoted 0 times

...

Ligia

5 months ago

I think Empagliflozin is the one that decreases glucose reabsorption, but I'm not completely sure.

upvoted 0 times

...

Evangelina

5 months ago

I've got this! Empagliflozin is the SGLT2 inhibitor that reduces glucose reabsorption, so that's got to be the right answer.

upvoted 0 times

...

Alexis

5 months ago

I'm a bit confused by the options, but I think I can eliminate a few based on their known mechanisms. Let me think this through step-by-step.

upvoted 0 times

...

Ligia

5 months ago

Okay, I remember learning about SGLT2 inhibitors like empagliflozin that work by decreasing glucose reabsorption in the kidneys. That seems like the most likely answer here.

upvoted 0 times

...

Alfred

5 months ago

Hmm, I'm not too familiar with the specific mechanisms of these drugs. I'll have to think this through carefully.

upvoted 0 times

...

Yuette

5 months ago

This looks like a pharmacology question, so I'll need to recall my knowledge of different antidiabetic medications and their mechanisms of action.

upvoted 0 times

...

Johnetta

10 months ago

Empagliflozin FTW! I'm gonna crush this exam. Now, where did I put my lucky rabbit's foot?

upvoted 0 times

...

Afton

10 months ago

Hmm, Pioglitazone is a thiazolidinedione that works on insulin sensitivity. I don't think that's the right answer for decreasing glucose reabsorption.

upvoted 0 times

Luis

9 months ago

User 3: Yeah, Pioglitazone works on insulin sensitivity, not glucose reabsorption.

upvoted 0 times

...

Idella

9 months ago

User 2: I agree, Empagliflozin works by decreasing glucose reabsorption.

upvoted 0 times

...

Chauncey

9 months ago

User 1: I think the answer is E) Empagliflozin.

upvoted 0 times

...

Chau

10 months ago

I'm pretty sure Exenatide is a GLP-1 agonist, not a glucose reabsorption inhibitor. Maybe I should have paid more attention in pharmacology class.

upvoted 0 times

Han

9 months ago

User 3: So, which medication actually works by decreasing glucose reabsorption?

upvoted 0 times

...

Precious

9 months ago

You're right, Exenatide is a GLP-1 agonist.

upvoted 0 times

...

Loreen

9 months ago

E) Empagliflozin works by inhibiting SGLT2.

upvoted 0 times

...

Cecily

9 months ago

User 2: Yeah, it doesn't decrease glucose reabsorption.

upvoted 0 times

...

Serina

9 months ago

B) Linagliptin is a DPP-4 inhibitor.

upvoted 0 times

...

Santos

10 months ago

User 1: I think you're right, Exenatide is a GLP-1 agonist.

upvoted 0 times

...

Sommer

10 months ago

A) Miglitol works by decreasing glucose reabsorption.

upvoted 0 times

...

Tegan

10 months ago

Empagliflozin, the SGLT2 inhibitor, is the correct answer. It works by decreasing glucose reabsorption in the kidneys. Gotta love those diuretic effects!

upvoted 0 times

...